MSME (Udyam registered) Ministry of MSME
- Category
- Small (2020-21)
- Udyam number
- UDYAM-TS-02-0005161
Tusker Pharma India Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2019
₹40.3 Cr
▲ 261% YoY
Net profit · FY 2019
₹16.25 Lakh
Net margin 0.4%
EBITDA · FY 2019
₹1.41 Cr
EBITDA margin 3.5%
Authorised capital
₹3.33 Cr
Registered with MCA
Paid-up capital
₹2.51 Cr
Issued & subscribed
Open charges
₹10.36 Cr
Secured borrowings
Company age
11 yrs
Est. 2015
Directors on board
2
As per MCA filings
About Tusker Pharma India Private Limited
Data last updated:
Tusker Pharma India Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 10 August 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG2015PTC100140. Its GSTIN is 36AAFCT4432R1ZS (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹3.33 Cr and a paid-up capital of ₹2.51 Cr. It was formerly known as Tusker Pharma Private Limited. It is led by directors Kommera Harish and Chintalapati Sesha Sai Nikhil.
Its last annual general meeting (AGM) was held on 12 August 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at 8 – 2 – 351/W/3/B Firstfloor Lanenexttorangoliroadno.3 Banjarahills, Hyderabad, Telangana, India – 500034.
As per the financials filed for FY 2019, the company reported a revenue of ₹40.3 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹16.25 Lakh (net margin 0.4%) and EBITDA of ₹1.41 Cr (EBITDA margin 3.5%). Revenue has grown at a compounded annual rate (CAGR) of 245% over three years.
The company is associated with 1 brand: Tusker Pharma. As per MCA filings, the company has open charges of ₹10.36 Cr on record. Court records list 15 cases involving the company, including 3 filed by the company and 12 filed against it.
Tusker Pharma India Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0005161). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website tuskerpharma.com.
Company details
CIN U24100TG2015PTC100140
Registration Number 100140
Incorporation Date 10 August 2015
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 12 August 2019
Date of Balance Sheet 31 March 2019
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-02-0005161
Recognitions & Rankings of Tusker Pharma India
Contact details
Tusker Pharma India Private Limited's registered office is in Hyderabad, Telangana. Its website is tuskerpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address8 – 2 – 351/W/3/B Firstfloor Lanenexttorangoliroadno.3 Banjarahills, Hyderabad, Telangana, India – 500034
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Tusker Pharma India Private Limited, buy the company report.
Comprehensive company report
Tusker Pharma India Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Tusker Pharma India operates one associated brand: Tusker Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Produces high-quality pharmaceutical products for health and wellness. | tuskerpharma.com |
Business activity
The main business activity of Tusker Pharma India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Tusker Pharma India Private Limited, buy the company report.
Financials of Tusker Pharma India Private Limited
FY 2019 filings availableTusker Pharma India Private Limited reported revenue of ₹40.3 Cr (up 261% YoY) for FY 2019.
Revenue · FY 2019
₹40.3 Cr ▲ 261%
Net profit · FY 2019
₹16.25 Lakh margin 0.4%
EBITDA · FY 2019
₹1.41 Cr margin 3.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 261%
3 years · compounded
▲ 245%
EBITDA CAGR growth
1 year
▲ 111%
3 years · compounded
▲ 261%
Revenue has grown at a compounded annual rate (CAGR) of 245% over three years, including 261% growth in the latest year. EBITDA rose 111% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ₹40.3 Cr | |||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹1.41 Cr | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹16.25 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 3.5% | |||
| Net Profit Margin | 0.4% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Tusker Pharma India Private Limited, buy the company report.
Board of directors of Tusker Pharma India Private Limited
Tusker Pharma India has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kommera Harish Also directs: Alsys Research LLP | Director | 10 Aug 2015 | 11 Years 3 Months | Current |
| Chintalapati Sesha Sai Nikhil | Director | 10 Aug 2015 | 11 Years 3 Months | Current |
Peer comparison
Tusker Pharma India Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Alas Pharmaceuticals Private Limited | ₹40.4 Cr (FY 2021) | Pune, Maharashtra, India | ||||
| Siflon Drugs and Pharmaceuticals Private Limited | ₹40.38 Cr (FY 2025) | 38.0% | Hyderabad, Telangana, India | |||
| Yacca Pharmaceuticals Private Limited | ₹40.38 Cr (FY 2024) | 6.0% | Uttar Pradesh, India | |||
| Canary Agro Chemicals Private Limited | ₹40.37 Cr (FY 2024) | -12.0% | Delhi, India | |||
| Vindas Chemical Industries Private Limited | ₹40.36 Cr (FY 2025) | 74.0% | Dhar, Madhya Pradesh, India | |||
| Tusker Pharma India Private Limitedthis company | ₹40.3 Cr (FY 2019) | ₹16.25 Lakh | 0.4% | 261.0% | Hyderabad, Telangana, India | |
| Raigad Chemicals Pvto Ltd | ₹40.27 Cr (FY 2025) | 39.0% | Thane, Maharashtra, India | |||
| Galaxy Medicare Limited | ₹40.27 Cr (FY 2025) | 9.0% | Bhubaneswar, Odisha, India | |||
| Lepro Herbals Private Limited | ₹40.25 Cr (FY 2025) | -4.0% | New Delhi, Delhi, India | |||
| Mahadhan Farm Technologies Private Limited | ₹40.24 Cr (FY 2023) | -8.0% | Mumbai, Maharashtra, India | |||
| Wincoat Colours and Coatings Private Limited | ₹40.21 Cr (FY 2025) | 21.0% | Thane, Maharashtra, India |
To see the full peer comparison of Tusker Pharma India Private Limited, buy the company report.
Auditor
Tusker Pharma India Private Limited is audited by JAMI & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| JAMI & CO | FY 2019 | 018314S |
Shareholding
The shareholding of Tusker Pharma India Private Limited is on record for 2 financial years, the latest being FY 2019, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2018 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Tusker Pharma India Private Limited, buy the company report.
Charges & borrowings
Open charges
₹10.36 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Nov 2020 | 100408296 | Axis Bank Limited | ₹35.71 Lakh | Open | |
| 01 Jan 2018 | 100155469 | Others | ₹10 Cr | Open |
Total charge records: 2 View all charges
Legal cases
Tusker Pharma India Private Limited has 15 court cases on record: 3 filed by Tusker Pharma India, 12 filed against it. All cases are disposed.
Total cases
15
Filed by the company
3
Filed against the company
12
Disposed
15
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 11 | 11 | 0 |
| High courts | 4 | 1 | 0 |
Cases on record (5 of 15)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Hyderabad Central, Telangana | Cheque dishonour complaint | Filed against the company by HDFC Bank Ltd., Rep. by Mr. T. Ajay Kumar | Disposed |
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by Neogrowth Credit Pvt. Ltd. | Disposed |
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed against the company by Kotak Mahindra Bank Ltd | Disposed |
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by Poonawalla Fincorp Ltd. | Disposed |
| High Court, TELANGANA | Writ petition | Filed by the company against Assistant Commissioner of State Tax and 3 others | Disposed |
To see the full case history of Tusker Pharma India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Tusker Pharma India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Tusker Pharma India has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAFCT4432R1ZS | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Tusker Pharma India Private Limited, buy the company report.
Recent activity
Tusker Pharma India Private Limited has 6 board changes on record since 2015: 2 appointments and 4 cessations. The latest: Jyotsna Kompalli ceased to be Director on 28 Dec 2017.
Charges
A charge with Axis Bank Limited amounted to Rs. 0.36 Cr with Charge ID 100408296 was registered on 26 Nov 2020.
AGM
Tusker Pharma India Private Limited last Annual general meeting of members was held on 12 Aug 2019 as per latest MCA records.
Filing
Tusker Pharma India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Hyderabad.
Charges
A charge with Others amounted to Rs. 10.00 Cr with Charge ID 100155469 was registered on 01 Jan 2018.
Ceased
Jyotsna Kompalli ceased to be Director.
Ceased
Charukula Saikiran ceased to be Additional Director.
Ceased
Anil Kumar Nair ceased to be Additional Director.
Ceased
Ashok Rengasamy ceased to be Additional Director.
Appointed
Chintalapati Sesha Sai Nikhil was appointed as Director.
Appointed
Kommera Harish was appointed as Director.
Incorporation
10 Aug 2015
Tusker Pharma India Private Limited was registered on 10 Aug 2015 with Roc Hyderabad & aged 11 years 3 months as per MCA records.
Frequently asked questions
Tusker Pharma India is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 10 August 2015 (11+ years old) and is registered under CIN U24100TG2015PTC100140.
Tusker Pharma India has 2 current directors:
- Kommera Harish - Director
- Chintalapati Sesha Sai Nikhil - Director
The latest financial statements of Tusker Pharma India on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 12 August 2019. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Tusker Pharma India is 36AAFCT4432R1ZS, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Tusker Pharma India is U24100TG2015PTC100140. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Tusker Pharma India has 15 court cases on record: 3 filed by the company and 12 filed against it. Most are in the district courts.
Tusker Pharma India was incorporated on 10 August 2015, making it 11+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Tusker Pharma India by revenue are Alas Pharmaceuticals Private Limited, Siflon Drugs and Pharmaceuticals Private Limited, Yacca Pharmaceuticals Private Limited, Canary Agro Chemicals Private Limited, Vindas Chemical Industries Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Jyotsna Kompalli ceased to be Director on 28 Dec 2017. Charukula Saikiran ceased to be Additional Director on 24 Apr 2017. Anil Kumar Nair ceased to be Additional Director on 02 Jan 2017. Tusker Pharma India has 6 board changes on record in total.
Yes, Tusker Pharma India is registered as a small enterprise under Udyam registration (number: UDYAM-TS-02-0005161).
Tusker Pharma India can be reached through the website tuskerpharma.com. Its registered office is in Hyderabad, Telangana, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages